Gemcitabine 1000mg Injection Citafine

Trade Name: Citafine

Manufacturer: Emcure Pharmaceuticals Ltd

Presentation: Injection

Strength: 1000mg

What is the best way to administer a Gemcitabine 1000mg Injection?

Gemcitabine 1000mg Injection is available as a powder that must be combined with fluids and injected intravenously (into a vein) by a doctor or nurse in a medical institution over the course of 30 minutes. Gemcitabine is frequently given on specific days every three weeks to treat ovarian or breast cancer.

What is the purpose of gemcitabine?

Descriptions: Gemcitabine injection is used in combination with other drugs (e.g., carboplatin) to treat patients with advanced ovarian cancer who have relapsed after receiving previous cancer treatments for at least 6 months (platinum-based).

What are the negative effects of chemotherapy with Gemcitabine 1000mg Injection?

  • For people receiving gemcitabine, the following adverse effects are common (occurring in more than 30% of cases):
  • Symptoms of the flu (muscle pain, fever, headache, chills, fatigue)
  • It’s a fever (within 6-12 hours of the first dose).
  • Fatigue
  • nausea (mild)
  • Vomiting
  • Appetite problems
  • A rash on the skin
  • Blood counts are low.

When should you have gemcitabine?

Gemcitabine 1000mg Injection is a chemotherapy drug that is used to treat some cancers (including breast, lung, ovarian, and pancreatic). It’s a cancer-fighting medicine that slows or stops cancer cell proliferation.

What is the maximum amount of time you can take gemcitabine?

Gemcitabine is frequently administered over the course of multiple treatment cycles. This implies that you’ll take the medicine and then take a break to let your body recuperate. A gemcitabine cycle usually lasts 3 to 4 weeks (21 to 28 days). Gemcitabine is commonly given once a week for two or three weeks, followed by a week without treatment.

What is the effectiveness of gemcitabine?

Since 1997, gemcitabine therapy has been the conventional first-line treatment for unresectable locally advanced or metastatic pancreatic cancer patients. The 5-year survival rate for patients with metastatic illness is barely 2%,1 and 1-year survival rates of 17 to 23 percent have been recorded with gemcitabine.

Is Gemcitabine 1000mg Injection a drug that weakens the immune system?

According to this study, gemcitabine produces a significant reduction in lymphocytes. It suppresses the humoral immune response while sparing antigen-specific cellular immunity.

Gemcitabine is used to treat a number of malignancies.

One of the most promising new cytotoxic agents is gemcitabine, which is a pyrimidine nucleoside antimetabolite. The medicine has been licensed to treat non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer after showing action in a range of solid tumors.

If you are looking for another product or brand click on our products.